CompletedNot applicableNCT04490850

COVID-19 Seroprevalence Study in French Guiana

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institut Pasteur
Principal Investigator
Claude Flamand, PhD
Institut Pasteur de la Guyane, Head of Epidemiology Unit
Intervention
Blood sample(procedure)
Enrollment
3541 target
Eligibility
All sexes
Timeline
2020 – 2021

Study locations (5)

Collaborators

Institut Pasteur de la Guyane · Laboratoire de biologie médicale, Institut Pasteur de la Guyane · Laboratoire de biologie médicale de Kourou, French Guiana · Laboratoire de biologie médicale du Centre hospitalier de Saint-Laurent du Maroni, French Guiana · Eurofins · Centres Délocalisés de Prévention et de Soins, Centre Hospitalier Andrée Rosemon de Cayenne, Frech Guiana

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04490850 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome →

← Back to all trials